Inhibition of the Blood Vessels Surrounding a Tumor
Showing 1 - 25 of >10,000
Circulating Tumor Cells (CTC) in Cancer
Recruiting
- Cancer
- Blood samples
- Samples from tumor draining vessels
-
Basel, Switzerland
- +1 more
Nov 8, 2021
Hepatocellular Cancer, Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial run by the NCI (durvalumab,
Recruiting
- Hepatocellular Cancer
- +2 more
- durvalumab
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Hepatocellular Carcinoma (HCC) Trial in Taiwan, United States (IA therapy of HCC with CSR02-Fab-TF)
Recruiting
- Hepatocellular Carcinoma (HCC)
- IA therapy of HCC with CSR02-Fab-TF
-
Saint Louis, Missouri
- +6 more
Aug 16, 2022
Tumor Microenvironment Analysis of Prostate Cancer Metastasis
Recruiting
- Recurrent Prostate Cancer
- Biopsy
-
New York, New YorkColumbia University Medical Center
Mar 22, 2022
Small Cell Lung Cancer Trial in Nice (acetazolamide in combination with platinum and etoposide-based radiochemo)
Recruiting
- Small Cell Lung Cancer
- acetazolamide in combination with platinum and etoposide-based radiochemotherapy
-
Nice, FranceCentre Antoine Lacassagne
Jan 19, 2023
Depressive Disorder, Major, Inflammation Trial (Infliximab, Placebo)
Not yet recruiting
- Depressive Disorder, Major
- Inflammation
- Infliximab
- Placebo
- (no location specified)
Nov 21, 2023
Solid Tumor, Adult Trial in Jacksonville (Human Intravital Microscopy)
Recruiting
- Solid Tumor, Adult
- Human Intravital Microscopy
-
Jacksonville, FloridaMayo Clinic Florida
Apr 4, 2022
Congenital Heart Disease Trial (Partial Heart Transplantation, Freshly procured valve)
Not yet recruiting
- Congenital Heart Disease
- Partial Heart Transplantation
- Freshly procured valve
- (no location specified)
Sep 20, 2023
Non-contrast Enhanced Cardiac Magnetic Resonance Normal Values
Recruiting
- Healthy
-
Graz, Styria, AustriaMedical Unitersity Graz, Department of Radiology, Division of Ge
May 2, 2022
SBRT in Reirradiation for Ultra-central Thoracic Malignant
Recruiting
- Stereotactic Body Radiation Therapy
- +3 more
- stereotacitic body radiation therapy
-
Beijing, Beijing, ChinaPeking University Third Hospital
May 31, 2022
Peritoneal Carcinomatosis Trial in Jacksonville (Human Intravital Microscopy)
Active, not recruiting
- Peritoneal Carcinomatosis
- Human Intravital Microscopy
-
Jacksonville, FloridaMayo Clinic Florida
Jan 31, 2022
NSCLC Trial in Amsterdam (Ipilimumab, Cemiplimab, SBRT)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- Ipilimumab
- +2 more
-
Amsterdam, Noord-Holland, NetherlandsAntoni van Leeuwenhoek - Netherlands Cancer Institute
Jan 10, 2023
Malignant Tumor in the Head and Neck, Metastatic Malignant Tumor in the Head and Neck Trial in Seattle (other, procedure, drug)
Not yet recruiting
- Malignant Neoplasm in the Head and Neck
- Metastatic Malignant Neoplasm in the Head and Neck
- Iodixanol
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 11, 2022
Oligometastatic Prostate Cancer Trial in New York (Quemliclustat, Etrumadenant, Zimberelimab)
Not yet recruiting
- Oligometastatic Prostate Cancer
- Quemliclustat
- +3 more
-
New York, New YorkColumbia University Irving Medical Center / NewYork-Presbyterian
Jun 14, 2023
Non Small Cell Lung Cancer, EGFR Gene Mutation, Immune Checkpoint Inhibitor Trial in Jerusalem (concomitant TTFields treatment
Not yet recruiting
- Non Small Cell Lung Cancer
- +2 more
- concomitant TTFields treatment device to standard of care EGFR positive NSCLC treatment
- concomitant TTFields treatment device to standard of care anti PD-1 NSCLC treatment
-
Jerusalem, IsraelShaare Zedek Medical Center
Jan 22, 2023
Squamous Cell Carcinoma of the Head and Neck Trial in Stanford ([18F]F-AraG PET Scan, baseline + post anti-PD-1 therapy.)
Completed
- Squamous Cell Carcinoma of the Head and Neck
- [18F]F-AraG PET Scan, baseline + post anti-PD-1 therapy.
-
Stanford, CaliforniaStanford Hospital and Clinics
Dec 1, 2022
Melanoma, NSCLC Trial (Evaluation of ctDNA using the F1T after 1 year of immunotherapy)
Not yet recruiting
- Melanoma
- Non-small Cell Lung Cancer
- Evaluation of ctDNA using the F1T after 1 year of immunotherapy
- (no location specified)
Nov 24, 2023
Glioma, Blood Platelets, Inflammation Trial in Paris (Platelet count in excised tumors)
Not yet recruiting
- Glioma
- +3 more
- Platelet count in excised tumors
-
Paris, FranceFondation A De Rothschild
Jun 8, 2022
Type 1 Diabetes, Type 2 Diabetes Trial in Stockholm (N?-hydroxy-nor-arginine)
Recruiting
- Type 1 Diabetes
- Type 2 Diabetes
- Nω-hydroxy-nor-arginine
-
Stockholm, SwedenKarolinska Institutet
Apr 10, 2023
Uterine Cervical Tumors, Endometrial Tumors, Lymphedema Trial in Chongqing (Prophylactic lymphedema treatment)
Recruiting
- Uterine Cervical Neoplasms
- +3 more
- Prophylactic lymphedema treatment
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
Mar 20, 2023
Solid Tumor, ARID1A Gene Mutation Trial in Greenville (Tazemetostat)
Suspended
- Solid Tumor
- ARID1A Gene Mutation
-
Greenville, South CarolinaPrisma Health Cancer Institute
Jan 10, 2023
Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)
Not yet recruiting
- Metastatic Pancreatic Cancer
- Durvalumab
- Rintatolimod
-
Rotterdam, Zuid-Holland, NetherlandsErasmus MC
Jun 23, 2023
Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Stage I Ovarian Cancer Trial in Buffalo (procedure, drug, other)
Completed
- Fallopian Tube Carcinoma
- +14 more
- Diagnostic Microscopy
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 5, 2021
Anti-cancer Immune Checkpoint Inhibition TowardsBetter
Not yet recruiting
- Cancer
- (no location specified)
Aug 1, 2023